mrna vaccine

Moderna's Covid-19 vaccine is 95% effective in preventing disease, but what's more impressive is that the company designed its vaccine in just two days in January 2020.

A new discovery about

The vaccine being tested is based on the use of non-pathogenic viruses with anti-cancer activity, which are introduced into the patient's body.

The mRNA vaccine to prevent melanoma is expected to launch in 2025, after being approved by US and European regulators.

Injecting the nCoV antigen test, the mouse's body has a good immune response, producing antibodies, promising initial success in creating a vaccine against Covid-19.